Alcohol consumption and HIV disease progression
- PMID: 17667330
- PMCID: PMC2247363
- DOI: 10.1097/QAI.0b013e318142aabb
Alcohol consumption and HIV disease progression
Abstract
Objective: To assess the relation between alcohol consumption and laboratory markers of HIV disease progression.
Methods: We prospectively assessed CD4 cell counts, HIV RNA levels, and alcohol consumption for up to 7 years in 595 HIV-infected persons with alcohol problems recruited between 1997 and 2003. We investigated the relation of these markers of HIV disease progression to alcohol consumption using longitudinal regression models controlling for known prognostic factors, including adherence and depressive symptoms, and stratified by antiretroviral therapy (ART) use.
Results: Among subjects who were not on ART, heavy alcohol consumption was associated with a lower CD4 cell count (adjusted mean decrease of 48.6 cells/microL compared with abstinence; P = 0.03) but not with higher log(10) HIV RNA. Among subjects who were on ART, heavy alcohol consumption was not associated with a lower CD4 cell count or higher log(10) HIV RNA.
Conclusions: Heavy alcohol consumption has a negative impact on the CD4 cell count in HIV-infected persons not receiving ART. In addition to the known deleterious effects of alcohol on ART adherence, these findings suggest that avoiding heavy alcohol consumption in patients not on ART may have a beneficial effect on HIV disease progression.
Comment in
-
Alcohol consumption and HIV disease progression--are heavy drinkers always drinking heavily?J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):364-5; author reply 365. doi: 10.1097/QAI.0b013e31817af48b. J Acquir Immune Defic Syndr. 2008. PMID: 18580341 No abstract available.
References
-
- Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet. 2000;356:1800–1805. - PubMed
-
- Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285:1466–1474. - PubMed
-
- Palella FJ, Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860. - PubMed
-
- Conigliaro J, Gordon AJ, McGinnis KA, et al. How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? J Acquir Immune Defic Syndr. 2003;33:521–525. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K24 AA015674/AA/NIAAA NIH HHS/United States
- M01 RR000533/RR/NCRR NIH HHS/United States
- K24-AA015674/AA/NIAAA NIH HHS/United States
- M01 RR001032/RR/NCRR NIH HHS/United States
- R01 AA013216/AA/NIAAA NIH HHS/United States
- R01-AA10870/AA/NIAAA NIH HHS/United States
- R01-AA13216/AA/NIAAA NIH HHS/United States
- M01 RR01032/RR/NCRR NIH HHS/United States
- M01 RR00533/RR/NCRR NIH HHS/United States
- R01 AA010870/AA/NIAAA NIH HHS/United States
- R01 AA011785/AA/NIAAA NIH HHS/United States
- R01-AA11785/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
